The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Bivalirudin Drug-Global Market Insights and Sales Trends 2025
Synopsis
Bivalirudin (Angiomax or Angiox, manufactured by The Medicines Company) is a direct thrombin inhibitor (DTI).
The global Bivalirudin Drug market size is expected to reach US$ 887.2 million by 2029, growing at a CAGR of 6.5% from 2023 to 2029. The market is mainly driven by the significant applications of Bivalirudin Drug in various end use industries. The expanding demands from the Hospital and Drug Store, are propelling Bivalirudin Drug market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Powder segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bivalirudin Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bivalirudin Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bivalirudin Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bivalirudin Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bivalirudin Drug covered in this report include The Medicines Company, Sandoz, Fresenius Kabi, Pfizer, Mylan, Dr. Reddy's Laboratories, Apotex, Accord Healthcare and Aurobindo Pharma, etc.
The global Bivalirudin Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
The Medicines Company
Sandoz
Fresenius Kabi
Pfizer
Mylan
Dr. Reddy's Laboratories
Apotex
Accord Healthcare
Aurobindo Pharma
Global Bivalirudin Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bivalirudin Drug market, Segment by Type:
Injection
Powder
Global Bivalirudin Drug market, by Application
Hospital
Drug Store
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Bivalirudin Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Bivalirudin Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Bivalirudin (Angiomax or Angiox, manufactured by The Medicines Company) is a direct thrombin inhibitor (DTI).
The global Bivalirudin Drug market size is expected to reach US$ 887.2 million by 2029, growing at a CAGR of 6.5% from 2023 to 2029. The market is mainly driven by the significant applications of Bivalirudin Drug in various end use industries. The expanding demands from the Hospital and Drug Store, are propelling Bivalirudin Drug market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Powder segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bivalirudin Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bivalirudin Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bivalirudin Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bivalirudin Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bivalirudin Drug covered in this report include The Medicines Company, Sandoz, Fresenius Kabi, Pfizer, Mylan, Dr. Reddy's Laboratories, Apotex, Accord Healthcare and Aurobindo Pharma, etc.
The global Bivalirudin Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
The Medicines Company
Sandoz
Fresenius Kabi
Pfizer
Mylan
Dr. Reddy's Laboratories
Apotex
Accord Healthcare
Aurobindo Pharma
Global Bivalirudin Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bivalirudin Drug market, Segment by Type:
Injection
Powder
Global Bivalirudin Drug market, by Application
Hospital
Drug Store
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Bivalirudin Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Bivalirudin Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Bivalirudin Drug Market Overview
1.1 Bivalirudin Drug Product Overview
1.2 Bivalirudin Drug Market Segment by Type
1.2.1 Injection
1.2.2 Powder
1.3 Global Bivalirudin Drug Market Size by Type
1.3.1 Global Bivalirudin Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Bivalirudin Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global Bivalirudin Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Bivalirudin Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe Bivalirudin Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Bivalirudin Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Bivalirudin Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Bivalirudin Drug Sales Breakdown by Type (2018-2023)
2 Global Bivalirudin Drug Market Competition by Company
2.1 Global Top Players by Bivalirudin Drug Sales (2018-2023)
2.2 Global Top Players by Bivalirudin Drug Revenue (2018-2023)
2.3 Global Top Players by Bivalirudin Drug Price (2018-2023)
2.4 Global Top Manufacturers Bivalirudin Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Bivalirudin Drug Market Competitive Situation and Trends
2.5.1 Bivalirudin Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Bivalirudin Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bivalirudin Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Bivalirudin Drug Market
2.8 Key Manufacturers Bivalirudin Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Bivalirudin Drug Status and Outlook by Region
3.1 Global Bivalirudin Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Bivalirudin Drug Historic Market Size by Region
3.2.1 Global Bivalirudin Drug Sales in Volume by Region (2018-2023)
3.2.2 Global Bivalirudin Drug Sales in Value by Region (2018-2023)
3.2.3 Global Bivalirudin Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Bivalirudin Drug Forecasted Market Size by Region
3.3.1 Global Bivalirudin Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Bivalirudin Drug Sales in Value by Region (2024-2029)
3.3.3 Global Bivalirudin Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Bivalirudin Drug by Application
4.1 Bivalirudin Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Drug Store
4.2 Global Bivalirudin Drug Market Size by Application
4.2.1 Global Bivalirudin Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Bivalirudin Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global Bivalirudin Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Bivalirudin Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe Bivalirudin Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Bivalirudin Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Bivalirudin Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Bivalirudin Drug Sales Breakdown by Application (2018-2023)
5 North America Bivalirudin Drug by Country
5.1 North America Bivalirudin Drug Historic Market Size by Country
5.1.1 North America Bivalirudin Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Bivalirudin Drug Sales in Volume by Country (2018-2023)
5.1.3 North America Bivalirudin Drug Sales in Value by Country (2018-2023)
5.2 North America Bivalirudin Drug Forecasted Market Size by Country
5.2.1 North America Bivalirudin Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Bivalirudin Drug Sales in Value by Country (2024-2029)
6 Europe Bivalirudin Drug by Country
6.1 Europe Bivalirudin Drug Historic Market Size by Country
6.1.1 Europe Bivalirudin Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Bivalirudin Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe Bivalirudin Drug Sales in Value by Country (2018-2023)
6.2 Europe Bivalirudin Drug Forecasted Market Size by Country
6.2.1 Europe Bivalirudin Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Bivalirudin Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Bivalirudin Drug by Region
7.1 Asia-Pacific Bivalirudin Drug Historic Market Size by Region
7.1.1 Asia-Pacific Bivalirudin Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Bivalirudin Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Bivalirudin Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Bivalirudin Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Bivalirudin Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Bivalirudin Drug Sales in Value by Region (2024-2029)
8 Latin America Bivalirudin Drug by Country
8.1 Latin America Bivalirudin Drug Historic Market Size by Country
8.1.1 Latin America Bivalirudin Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Bivalirudin Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America Bivalirudin Drug Sales in Value by Country (2018-2023)
8.2 Latin America Bivalirudin Drug Forecasted Market Size by Country
8.2.1 Latin America Bivalirudin Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Bivalirudin Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Bivalirudin Drug by Country
9.1 Middle East and Africa Bivalirudin Drug Historic Market Size by Country
9.1.1 Middle East and Africa Bivalirudin Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Bivalirudin Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Bivalirudin Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Bivalirudin Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Bivalirudin Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Bivalirudin Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 The Medicines Company
10.1.1 The Medicines Company Company Information
10.1.2 The Medicines Company Introduction and Business Overview
10.1.3 The Medicines Company Bivalirudin Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 The Medicines Company Bivalirudin Drug Products Offered
10.1.5 The Medicines Company Recent Development
10.2 Sandoz
10.2.1 Sandoz Company Information
10.2.2 Sandoz Introduction and Business Overview
10.2.3 Sandoz Bivalirudin Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sandoz Bivalirudin Drug Products Offered
10.2.5 Sandoz Recent Development
10.3 Fresenius Kabi
10.3.1 Fresenius Kabi Company Information
10.3.2 Fresenius Kabi Introduction and Business Overview
10.3.3 Fresenius Kabi Bivalirudin Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Fresenius Kabi Bivalirudin Drug Products Offered
10.3.5 Fresenius Kabi Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Bivalirudin Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Bivalirudin Drug Products Offered
10.4.5 Pfizer Recent Development
10.5 Mylan
10.5.1 Mylan Company Information
10.5.2 Mylan Introduction and Business Overview
10.5.3 Mylan Bivalirudin Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Mylan Bivalirudin Drug Products Offered
10.5.5 Mylan Recent Development
10.6 Dr. Reddy's Laboratories
10.6.1 Dr. Reddy's Laboratories Company Information
10.6.2 Dr. Reddy's Laboratories Introduction and Business Overview
10.6.3 Dr. Reddy's Laboratories Bivalirudin Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Dr. Reddy's Laboratories Bivalirudin Drug Products Offered
10.6.5 Dr. Reddy's Laboratories Recent Development
10.7 Apotex
10.7.1 Apotex Company Information
10.7.2 Apotex Introduction and Business Overview
10.7.3 Apotex Bivalirudin Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Apotex Bivalirudin Drug Products Offered
10.7.5 Apotex Recent Development
10.8 Accord Healthcare
10.8.1 Accord Healthcare Company Information
10.8.2 Accord Healthcare Introduction and Business Overview
10.8.3 Accord Healthcare Bivalirudin Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Accord Healthcare Bivalirudin Drug Products Offered
10.8.5 Accord Healthcare Recent Development
10.9 Aurobindo Pharma
10.9.1 Aurobindo Pharma Company Information
10.9.2 Aurobindo Pharma Introduction and Business Overview
10.9.3 Aurobindo Pharma Bivalirudin Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Aurobindo Pharma Bivalirudin Drug Products Offered
10.9.5 Aurobindo Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Bivalirudin Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Bivalirudin Drug Industrial Chain Analysis
11.4 Bivalirudin Drug Market Dynamics
11.4.1 Bivalirudin Drug Industry Trends
11.4.2 Bivalirudin Drug Market Drivers
11.4.3 Bivalirudin Drug Market Challenges
11.4.4 Bivalirudin Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Bivalirudin Drug Distributors
12.3 Bivalirudin Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
